Company / Current Assets per Share
Sonoma Pharmaceuticals, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$16.21
FY2025
5-year range
$2.54 / $16.21
FY2021-FY2025
Trend
+537.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +537% YoY in FY2025, a notable deviation from the 8-year average annual change of +92%.
Based on SEC 10-K filings.
16.21 in FY2025 with a 5-year CAGR of +11.5%.
Improved from $4.45 to $16.21 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +27.3%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 537.2% year-over-year.
- Peak current assets per share was recorded in FY2019.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $16.21 | +537.2% |
| FY2024 | $2.54 | -42.8% |
| FY2023 | $4.45 | -43.3% |
| FY2022 | $7.85 | +7.5% |
| FY2021 | $7.30 | -22.4% |
| FY2020 | $9.41 | -48.4% |
| FY2019 | $18.22 | +380.9% |
| FY2018 | $3.79 | -29.8% |
| FY2017 | $5.40 | +529.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026